Glaxo Sues To Protect Zofran Patent
GlaxoSmithKline will go back to court to defend one of the patents for its anti-nausea drug Zofran, the challenge coming this time from generic drug maker Eon Laboratories....To view the full article, register now.
Already a subscriber? Click here to view full article